FR2031460A1 - - Google Patents

Info

Publication number
FR2031460A1
FR2031460A1 FR6940486A FR6940486A FR2031460A1 FR 2031460 A1 FR2031460 A1 FR 2031460A1 FR 6940486 A FR6940486 A FR 6940486A FR 6940486 A FR6940486 A FR 6940486A FR 2031460 A1 FR2031460 A1 FR 2031460A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR6940486A
Other versions
FR2031460B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of FR2031460A1 publication Critical patent/FR2031460A1/fr
Application granted granted Critical
Publication of FR2031460B1 publication Critical patent/FR2031460B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/32—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by an araliphatic carboxylic acid, which is substituted on the aliphatic radical by hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
FR696940486A 1969-02-17 1969-11-25 Expired FR2031460B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79999169A 1969-02-17 1969-02-17

Publications (2)

Publication Number Publication Date
FR2031460A1 true FR2031460A1 (fr) 1970-11-20
FR2031460B1 FR2031460B1 (fr) 1973-04-06

Family

ID=25177238

Family Applications (1)

Application Number Title Priority Date Filing Date
FR696940486A Expired FR2031460B1 (fr) 1969-02-17 1969-11-25

Country Status (17)

Country Link
US (1) US3496171A (fr)
AT (1) AT293618B (fr)
BE (1) BE742086A (fr)
BR (1) BR6914264D0 (fr)
CH (1) CH531006A (fr)
CS (1) CS157076B2 (fr)
CY (1) CY784A (fr)
DE (1) DE1958329C3 (fr)
ES (1) ES373868A1 (fr)
FR (1) FR2031460B1 (fr)
GB (1) GB1254148A (fr)
IE (1) IE33619B1 (fr)
IL (1) IL33326A (fr)
MY (1) MY7500052A (fr)
NL (1) NL6917696A (fr)
PL (1) PL83176B1 (fr)
SE (1) SE372536B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692781A (en) * 1971-02-26 1972-09-19 Glaxo Lab Ltd Recovery of pure cephalexin from acidic reaction mixtures
US4054738A (en) * 1975-12-22 1977-10-18 Eli Lilly And Company Sodium cefamandole crystalline forms
EP2566458B1 (fr) * 2010-05-04 2015-08-05 Mahmut Bilgic Formulations pharmaceutiques comprenant du céfuroxime axétil

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Also Published As

Publication number Publication date
IL33326A0 (en) 1970-01-29
DE1958329C3 (de) 1974-05-02
CH531006A (fr) 1972-11-30
NL6917696A (fr) 1970-08-19
DE1958329A1 (de) 1970-10-22
IE33619B1 (en) 1974-09-04
IE33619L (en) 1970-08-17
PL83176B1 (fr) 1975-12-31
GB1254148A (en) 1971-11-17
BE742086A (fr) 1970-05-25
MY7500052A (en) 1975-12-31
SE372536B (fr) 1974-12-23
US3496171A (en) 1970-02-17
AT293618B (de) 1971-10-25
CY784A (en) 1976-06-01
BR6914264D0 (pt) 1973-02-22
IL33326A (en) 1973-02-28
CS157076B2 (fr) 1974-08-23
ES373868A1 (es) 1972-02-16
FR2031460B1 (fr) 1973-04-06
DE1958329B2 (de) 1973-09-27

Similar Documents

Publication Publication Date Title
AU2270770A (fr)
AU465413B2 (fr)
AU4221168A (fr)
AU2355770A (fr)
FR2031460B1 (fr)
AU470301B1 (fr)
AU5113869A (fr)
AT308690B (fr)
AU470661B1 (fr)
AU428129B2 (fr)
AU417208B2 (fr)
AU410358B2 (fr)
AU414607B2 (fr)
AU1036070A (fr)
CS149307B1 (fr)
CS148402B1 (fr)
CS148060B2 (fr)
AU4923469A (fr)
AU4949169A (fr)
AU5077469A (fr)
AR203167Q (fr)
AU5079269A (fr)
CH1011569A4 (fr)
BE743432A (fr)
BE742108A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse